# Safety of TG100-115 for Heart Attack Treated With Angioplasty

> **NCT00103350** · PHASE1,PHASE2 · COMPLETED · sponsor: **TargeGen** · enrollment: 100 (—)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** TG100-115

## Key facts

- **NCT ID:** NCT00103350
- **Lead sponsor:** TargeGen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-12
- **Final completion:** 2008-01
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00103350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00103350, "Safety of TG100-115 for Heart Attack Treated With Angioplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00103350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*